Very recently, reduction of FXR expression was demonstrated in cholangiocarcinoma and biliary tract carcinoma [46], [47] and in tumor versus normal liver tissue from HCC patients [51], [52] and NDRG2 expression was found downregulated in gallbladder carcinoma with poor outcome [35]. Here, NR1H4 is linked to cholangiocarcinoma.